According to the new research report published by Precedence Research, titled “Generative AI in Personalized Medicine Market (By Personalized Medicine Therapeutics: Pharmaceutical, Genomic Medicine, Devices; By Deployment Model: On-premise, Cloud Based; By End-User: Hospitals and Clinics, Clinical Research, Healthcare Organizations, Diagnostic Centers) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032 (By Product: Traditional, Advanced; By Application: Pottery, Tiles, Abrasives, Sanitary wave, Bricks & pipes, Others; By End User: Medical, Industrial, Building & Construction, Others) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032”, The global generative AI in personalized medicine market is comprehensively and accurately detailed in the report, taking into consideration various factors such as competition, regional growth, segmentation, and market size by value and volume. The study investigates several elements and their consequences on the growth of the all-wheel drive market.
This report focuses on generative AI in personalized medicine market volume and value at the global level, regional level and company level. From a global perspective, this report represents the overall generative AI in personalized medicine market size by analysing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, the Middle East & Africa, Latin America, etc.
Key Takeaways:
- North America is expected to dominate in the generative AI in personalized medicine market during the forecast period.
- By personalized medicine therapeutics, the pharmaceutical segment is expected to hold a leading position in the generative AI in personalized medicine market.
- By deployment model, the cloud-based segment is expected to carry a significant share of the generative AI in personalized medicine market during the forecast period.
- By end-user, the hospitals and clinics segment shares the maximum CAGR during the projection period.
The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2032. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Download a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/3095
The study also provides important advancements in organic and inorganic growth strategies in the worldwide generative AI in personalized medicine market. A lot of corporations are prioritizing new launches, product approvals, and other business expansion techniques. In addition, the report offers profiles of generative AI in personalized medicine market firms and market strategies. Furthermore, the research focuses on top industry participants, providing information such as company profiles, components and services offered, recent financial data, and key developments.
Generative AI in Personalized Medicine Market Report Scope
| Report Coverage | Details |
| Largest Market | North America |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Personalized Medicine Therapeutics, By Deployment Model, and By End-User |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Also read: Gas Meter Market Size to Worth US$ 22.4 Billion By 2032
Major Key Points Covered in Report:
Executive Summary: It includes key trends of the electric vehicle fuel cell market related to products, applications, and other crucial factors. It also provides analysis of the competitive landscape and CAGR and market size of the electric vehicle fuel cell market based on production and revenue.
Production and Consumption by Region: It covers all regional markets to which the research study relates. Prices and key players in addition to production and consumption in each regional market are discussed.
Key Players: Here, the report throws light on financial ratios, pricing structure, production cost, gross profit, sales volume, revenue, and gross margin of leading and prominent companies competing in the Electric vehicle fuel cell market.
Market Segments: This part of the report discusses product, application and other segments of the electric vehicle fuel cell market based on market share, CAGR, market size, and various other factors.
Research Methodology: This section discusses the research methodology and approach used to prepare the report. It covers data triangulation, market breakdown, market size estimation, and research design and/or programs.
Market Key Players
Company profiles have been included in the report, which include essentials such as product portfolio, key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting market status and predicting the competition level in the generative AI in personalized medicine market.
Some of the prominent players in the generative AI in personalized medicine market include
- Butterfly Network
- Deep Genomics
- Google LLC
- IBM Watson Health
- Microsoft Corporation
- Aidoc
- Insilico Medicine
- PathAI
- Tencent Holdings Ltd.
- Neuralink Corporation
- Johnson & Johnson
Generative AI in Personalized Medicine Market Segmentations
By Personalized Medicine Therapeutics
- Pharmaceutical
- Genomic Medicine
- Devices
By Deployment Model
- On-premise
- Cloud Based
By End-User
- Hospitals and Clinics
- Clinical Research
- Healthcare Organizations
- Diagnostic Centers
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Report Objectives
- To define, segment, and project the global market size for generative AI in personalized medicine market
- To understand the structure of the market by identifying its various sub-segments
- To provide detailed information about the key factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
- To analyse the micro-markets, with respect to individual growth trends, future prospects, and their contributions to the total market
- To project the size of the market and its submarkets, in terms of value, with respect to global. (along with their respective key countries)
- To profile key players and comprehensively analyse their core competencies
- To understand the competitive landscape and identify major growth strategies adopted by players across the globe.
- To analyse the competitive developments such as expansions & investments, new product launches, mergers & acquisitions, joint ventures, and agreements
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Generative AI in Personalized Medicine Market
5.1. COVID-19 Landscape: Generative AI in Personalized Medicine Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Generative AI in Personalized Medicine Market, By Personalized Medicine Therapeutics
8.1. Generative AI in Personalized Medicine Market, by Personalized Medicine Therapeutics, 2023-2032
8.1.1 Pharmaceutical
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Genomic Medicine
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Devices
8.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Generative AI in Personalized Medicine Market, By Deployment Model
9.1. Generative AI in Personalized Medicine Market, by Deployment Model, 2023-2032
9.1.1. On-premise
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Cloud Based
9.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Generative AI in Personalized Medicine Market, By End-User
10.1. Generative AI in Personalized Medicine Market, by End-User, 2023-2032
10.1.1. Hospitals and Clinics
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Clinical Research
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Healthcare Organizations
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Diagnostic Centers
10.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Generative AI in Personalized Medicine Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Personalized Medicine Therapeutics (2020-2032)
11.1.2. Market Revenue and Forecast, by Deployment Model (2020-2032)
11.1.3. Market Revenue and Forecast, by End-User (2020-2032)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Personalized Medicine Therapeutics (2020-2032)
11.1.4.2. Market Revenue and Forecast, by Deployment Model (2020-2032)
11.1.4.3. Market Revenue and Forecast, by End-User (2020-2032)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Personalized Medicine Therapeutics (2020-2032)
11.1.5.2. Market Revenue and Forecast, by Deployment Model (2020-2032)
11.1.5.3. Market Revenue and Forecast, by End-User (2020-2032)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Personalized Medicine Therapeutics (2020-2032)
11.2.2. Market Revenue and Forecast, by Deployment Model (2020-2032)
11.2.3. Market Revenue and Forecast, by End-User (2020-2032)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Personalized Medicine Therapeutics (2020-2032)
11.2.4.2. Market Revenue and Forecast, by Deployment Model (2020-2032)
11.2.4.3. Market Revenue and Forecast, by End-User (2020-2032)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Personalized Medicine Therapeutics (2020-2032)
11.2.5.2. Market Revenue and Forecast, by Deployment Model (2020-2032)
11.2.5.3. Market Revenue and Forecast, by End-User (2020-2032)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Personalized Medicine Therapeutics (2020-2032)
11.2.6.2. Market Revenue and Forecast, by Deployment Model (2020-2032)
11.2.6.3. Market Revenue and Forecast, by End-User (2020-2032)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Personalized Medicine Therapeutics (2020-2032)
11.2.7.2. Market Revenue and Forecast, by Deployment Model (2020-2032)
11.2.7.3. Market Revenue and Forecast, by End-User (2020-2032)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Personalized Medicine Therapeutics (2020-2032)
11.3.2. Market Revenue and Forecast, by Deployment Model (2020-2032)
11.3.3. Market Revenue and Forecast, by End-User (2020-2032)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Personalized Medicine Therapeutics (2020-2032)
11.3.4.2. Market Revenue and Forecast, by Deployment Model (2020-2032)
11.3.4.3. Market Revenue and Forecast, by End-User (2020-2032)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Personalized Medicine Therapeutics (2020-2032)
11.3.5.2. Market Revenue and Forecast, by Deployment Model (2020-2032)
11.3.5.3. Market Revenue and Forecast, by End-User (2020-2032)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Personalized Medicine Therapeutics (2020-2032)
11.3.6.2. Market Revenue and Forecast, by Deployment Model (2020-2032)
11.3.6.3. Market Revenue and Forecast, by End-User (2020-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Personalized Medicine Therapeutics (2020-2032)
11.3.7.2. Market Revenue and Forecast, by Deployment Model (2020-2032)
11.3.7.3. Market Revenue and Forecast, by End-User (2020-2032)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Personalized Medicine Therapeutics (2020-2032)
11.4.2. Market Revenue and Forecast, by Deployment Model (2020-2032)
11.4.3. Market Revenue and Forecast, by End-User (2020-2032)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Personalized Medicine Therapeutics (2020-2032)
11.4.4.2. Market Revenue and Forecast, by Deployment Model (2020-2032)
11.4.4.3. Market Revenue and Forecast, by End-User (2020-2032)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Personalized Medicine Therapeutics (2020-2032)
11.4.5.2. Market Revenue and Forecast, by Deployment Model (2020-2032)
11.4.5.3. Market Revenue and Forecast, by End-User (2020-2032)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Personalized Medicine Therapeutics (2020-2032)
11.4.6.2. Market Revenue and Forecast, by Deployment Model (2020-2032)
11.4.6.3. Market Revenue and Forecast, by End-User (2020-2032)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Personalized Medicine Therapeutics (2020-2032)
11.4.7.2. Market Revenue and Forecast, by Deployment Model (2020-2032)
11.4.7.3. Market Revenue and Forecast, by End-User (2020-2032)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Personalized Medicine Therapeutics (2020-2032)
11.5.2. Market Revenue and Forecast, by Deployment Model (2020-2032)
11.5.3. Market Revenue and Forecast, by End-User (2020-2032)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Personalized Medicine Therapeutics (2020-2032)
11.5.4.2. Market Revenue and Forecast, by Deployment Model (2020-2032)
11.5.4.3. Market Revenue and Forecast, by End-User (2020-2032)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Personalized Medicine Therapeutics (2020-2032)
11.5.5.2. Market Revenue and Forecast, by Deployment Model (2020-2032)
11.5.5.3. Market Revenue and Forecast, by End-User (2020-2032)
Chapter 12. Company Profiles
12.1. Butterfly Network
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Deep Genomics
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Google LLC
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. IBM Watson Health
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Microsoft Corporation
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Aidoc
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Insilico Medicine
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. PathAI
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Tencent Holdings Ltd.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Neuralink Corporation
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Why should you invest in this report?
If you are aiming to enter the global generative AI in personalized medicine market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for generative AI in personalized medicine are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2023-2030 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
